🇺🇸 FDA
Patent

US 11642319

Targeted nanogels for urinary bladder therapies

granted A61KA61K31/496A61K31/7036

Quick answer

US patent 11642319 (Targeted nanogels for urinary bladder therapies) held by The Regents of the University of Colorado expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/496, A61K31/7036, A61K38/13, A61K41/0042